Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation-Reference-Cited by-同舟云学术

Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation

Published:2014-05 Issue:5 Volume:60 Page:1017-1025
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Castaño David,Larequi Eduardo,Belza Idoia,Astudillo Alma M.,Martínez-Ansó Eduardo,Balsinde Jesús,Argemi Josepmaria,Aragon Tomás,Moreno-Aliaga María J.,Muntane Jordi,Prieto Jesús,Bustos Matilde

Publisher

Elsevier BV

Subject

Hepatology

Reference32 articles.

1. The epidemiology of nonalcoholic fatty liver disease: a global perspective;Lazo;Semin Liver Dis,2008

2. The natural history of nonalcoholic fatty liver disease: a population-based cohort study;Adams;Gastroenterology,2005

3. Nonalcoholic fatty liver disease and lipids;Wierzbicki;Curr Opin Lipidol,2012

4. The lipogenic transcription factor CHREBP dissociates hepatic steatosis from insulin resistance in mice and humans;Benhamed;J Clin Invest,2012

5. Cardiotrophin-1 is a key regulator of glucose and lipid metabolism;Moreno-Aliaga;Cell Metab,2011

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic effect of genistein and adiponectin reduces fat deposition in chicken hepatocytes by activating the ERβ-mediated SIRT1-AMPK signaling pathway;Poultry Science;2024-06

2. Association between Human Blood Proteome and the Risk of Myocardial Infarction;Reviews in Cardiovascular Medicine;2024-05-30

3. G protein–coupled estrogen receptor 1 ameliorates nonalcoholic steatohepatitis through targeting AMPK-dependent signaling;Journal of Biological Chemistry;2024-03

4. Maresin 1 Exerts a Tissue-Specific Regulation of Adipo-Hepato-Myokines in Diet-Induced Obese Mice and Modulates Adipokine Expression in Cultured Human Adipocytes in Basal and Inflammatory Conditions;Biomolecules;2023-05-31

5. Serum Cardiotrophin-1 Concentration Is Negatively Associated with Controlled Attenuation Parameters in Subjects with Non-Alcoholic Fatty Liver Disease;Journal of Clinical Medicine;2023-04-06